Home > Financial Ratios > GENNEX LABORATORIES

GENNEX LABORATORIES
Core EBITDA Growth

    Back to All Ratios
GENNEX LABORATORIES is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for GENNEX LABORATORIES
Please provide your vote to see the results

GENNEX LABORATORIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Growth(%) 13.0323.75153.7027.91-4.23

What is the latest Core EBITDA Growth ratio of GENNEX LABORATORIES ?

The latest Core EBITDA Growth ratio of GENNEX LABORATORIES is 13.03 based on Mar2026 Consolidated results.
Year Core EBITDA Growth
Mar202613.03
Mar202523.75
Mar2024153.70
Mar202327.91
Mar2022-4.23

How is Core EBITDA Growth of GENNEX LABORATORIES Trending?

Years Core EBITDA Growth % Change
Mar2026 13.03
-45.14
Mar2025 23.75
-84.55
Mar2024 153.7
450.70
Mar2023 27.91
Positive
Mar2022 -4.23 -

Other Financial Ratios of GENNEX LABORATORIES


Compare Core EBITDA Growth ratio of peers of GENNEX LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENNEX LABORATORIES ₹224.8 Cr 15.3% -6.7% -42.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹437,963.0 Cr 2.7% 1.4% 4.3% Stock Analytics
DIVIS LABORATORIES ₹269,451.0 Cr 4.5% 6.3% 50.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹179,456.0 Cr 1.8% -1.3% 31.4% Stock Analytics
DR REDDYS LABORATORIES ₹113,664.0 Cr 0.8% 12.5% 14.1% Stock Analytics
CIPLA ₹113,246.0 Cr 1.6% 4.4% -9.1% Stock Analytics


GENNEX LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENNEX LABORATORIES

15.3%

-6.7%

-42.9%

SENSEX

7%

9.6%

-6.7%


You may also like the below Video Courses